Solaris Asset Management Decreased Cvs (CVS) Holding; Camden National (CAC) Sentiment Is 1.3

Solaris Asset Management Llc decreased Cvs Corp (CVS) stake by 96.09% reported in 2017Q3 SEC filing. Solaris Asset Management Llc sold 23,320 shares as Cvs Corp (CVS)’s stock declined 4.23%. The Solaris Asset Management Llc holds 950 shares with $77,000 value, down from 24,270 last quarter. Cvs Corp now has $70.79B valuation. The stock increased 0.69% or $0.48 during the last trading session, reaching $69.87. About 8.94M shares traded. CVS Health Corporation (NYSE:CVS) has declined 24.40% since February 13, 2017 and is downtrending. It has underperformed by 41.10% the S&P500.

Camden National Corporation operates as the holding firm for Camden National Bank that provides commercial and consumer banking services and products to consumer, institutional, municipal, non-profit, and commercial customers. The company has market cap of $657.47 million. It offers various deposit products, including demand, interest checking, saving, and money market accounts. It has a 23.27 P/E ratio. The firm also originates single family and multi-family residential loans, commercial real estate loans, business loans, municipal loans, and various consumer loans, as well as loans for the construction of residential homes, multi-family properties, and commercial real estate properties.

Minerva Advisors Llc holds 3.71% of its portfolio in Camden National Corporation for 160,658 shares. Clean Yield Group owns 45,399 shares or 0.81% of their US portfolio. Moreover, Basswood Capital Management L.L.C. has 0.65% invested in the company for 325,260 shares. The Pennsylvania-based Bryn Mawr Trust Co has invested 0.5% in the stock. Empirical Financial Services Llc, a Washington-based fund reported 47,019 shares.

The stock decreased 0.96% or $0.41 during the last trading session, reaching $42.35. About 20,817 shares traded. Camden National Corporation (CAC) has risen 42.48% since February 13, 2017 and is uptrending. It has outperformed by 25.78% the S&P500.

Among 25 analysts covering CVS Health (NYSE:CVS), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. CVS Health had 71 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Thursday, January 4 by Robert W. Baird. As per Wednesday, July 22, the company rating was maintained by Deutsche Bank. Citigroup maintained CVS Health Corporation (NYSE:CVS) on Thursday, August 17 with “Neutral” rating. The stock of CVS Health Corporation (NYSE:CVS) earned “Overweight” rating by JP Morgan on Monday, November 2. The stock of CVS Health Corporation (NYSE:CVS) earned “Buy” rating by Needham on Tuesday, January 30. Jefferies maintained the stock with “Hold” rating in Tuesday, November 7 report. The firm earned “Buy” rating on Tuesday, June 13 by Cowen & Co. The stock of CVS Health Corporation (NYSE:CVS) earned “Hold” rating by Jefferies on Wednesday, October 18. The firm earned “Hold” rating on Wednesday, August 16 by Jefferies. The rating was initiated by UBS with “Buy” on Thursday, October 6.